NOVAI
Reading, GB · 3 known investors
Novai develops DARC technology for early detection and intervention of eye and brain diseases, aiming to reduce blindness and disability. It serves patients, clinicians, and pharmaceutical companies within the ophthalmic and medical technology field, with a focus on the UK.
BiotechHealthtechMedical Devices
Investors · 3
Frequently asked questions
- What does NOVAI do?
- Novai develops DARC technology for early detection and intervention of eye and brain diseases, aiming to reduce blindness and disability. It serves patients, clinicians, and pharmaceutical companies within the ophthalmic and medical technology field, with a focus on the UK.
- Who are NOVAI's investors?
- NOVAI's investors include Anglia Capital Group, ExSight Ventures, Zinc.
- Where is NOVAI headquartered?
- NOVAI is headquartered in Reading, GB.